Cover Image

Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic

Background We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. Methods Patients with surgically treated oral cavity squamous cell carcinoma were assessed retro...

Full description

Saved in:
Bibliographic Details
Main Authors: Semmelmayer, Karl (Author) , Mrosek, Jan Bernd (Author) , Zittel, Sven (Author) , Pilz, Maximilian (Author) , Held, Thomas (Author) , Adeberg, Sebastian (Author) , Ristow, Oliver (Author) , Hoffmann, Jürgen (Author) , Engel, Michael (Author) , Freudlsperger, Christian (Author) , Moratin, Julius (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Head & neck
Year: 2021, Volume: 43, Issue: 11, Pages: 3493-3497
ISSN:1097-0347
DOI:10.1002/hed.26858
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/hed.26858
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.26858
Get full text
Author Notes:Karl Metzger, Jan Mrosek, Sven Zittel, Maximilian Pilz, Thomas Held, Sebastian Adeberg, Oliver Ristow, Jürgen Hoffmann, Michael Engel, Christian Freudlsperger, Julius Moratin
Description
Summary:Background We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. Methods Patients with surgically treated oral cavity squamous cell carcinoma were assessed retrospectively and divided into two groups depending on when they had first presented at our clinic. Patients presenting from 2010 to 2019, that is, before COVID-19 onset (n = 566) were compared to patients presenting in 2020 (n = 58). Results A total of 624 patients were included. Treatment delay was significantly longer in 2020 (median = 45 days) versus 2010-2019 (median = 35 days) (p = 0.004). We observed a higher pathological T classification in 2020 (p = 0.046), whereas pathological N classification was unchanged between groups (p = 0.843). Conclusions While extraordinary efforts continue to be made in the context of the pandemic, it is imperative that this does not lead to significant disadvantages for many people with oral cancer.
Item Description:Gesehen am 11.08.2023
Physical Description:Online Resource
ISSN:1097-0347
DOI:10.1002/hed.26858

Similar Items